Annual Non Current Assets
$714.30 K
+$505.70 K+242.43%
01 December 2023
Summary:
TransCode Therapeutics annual long term assets is currently $714.30 thousand, with the most recent change of +$505.70 thousand (+242.43%) on 01 December 2023. During the last 3 years, it has risen by +$508.00 thousand (+246.24%). RNAZ annual non current assets is now at all-time high.RNAZ Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$323.50 K
-$114.70 K-26.18%
01 September 2024
Summary:
TransCode Therapeutics quarterly long term assets is currently $323.50 thousand, with the most recent change of -$114.70 thousand (-26.18%) on 01 September 2024. Over the past year, it has dropped by -$390.80 thousand (-54.71%). RNAZ quarterly non current assets is now -73.99% below its all-time high of $1.24 million, reached on 31 March 2023.RNAZ Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAZ Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -54.7% |
| 3 y3 years | +246.2% | +56.8% |
| 5 y5 years | +100.0% | - |
RNAZ Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +246.2% | -74.0% | +56.8% |
| 5 y | 5 years | at high | -74.0% | +107.9% | |
| alltime | all time | at high | -74.0% | +107.9% |
TransCode Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $323.50 K(-26.2%) |
| June 2024 | - | $438.20 K(-24.0%) |
| Mar 2024 | - | $576.40 K(-19.3%) |
| Dec 2023 | $4.46 M(-39.6%) | $714.30 K(-16.4%) |
| Sept 2023 | - | $854.40 K(-13.6%) |
| June 2023 | - | $988.60 K(-20.5%) |
| Mar 2023 | - | $1.24 M(+496.3%) |
| Dec 2022 | $7.38 M | $208.60 K(-53.2%) |
| Sept 2022 | - | $445.70 K(+89.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $234.70 K(+9.0%) |
| Mar 2022 | - | $215.30 K(+4.4%) |
| Dec 2021 | $22.73 M(+2634.9%) | $206.30 K(+32.6%) |
| Sept 2021 | - | $155.60 K(-84.2%) |
| June 2021 | - | $982.00 K(+113.2%) |
| Mar 2021 | - | $460.60 K(+105.4%) |
| Dec 2020 | $831.20 K(+306.5%) | - |
| Dec 2020 | - | $224.20 K |
| Dec 2019 | $204.50 K | - |
FAQ
- What is TransCode Therapeutics annual long term assets?
- What is the all time high annual non current assets for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly non current assets year-on-year change?
What is TransCode Therapeutics annual long term assets?
The current annual non current assets of RNAZ is $714.30 K
What is the all time high annual non current assets for TransCode Therapeutics?
TransCode Therapeutics all-time high annual long term assets is $714.30 K
What is TransCode Therapeutics quarterly long term assets?
The current quarterly non current assets of RNAZ is $323.50 K
What is the all time high quarterly non current assets for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly long term assets is $1.24 M
What is TransCode Therapeutics quarterly non current assets year-on-year change?
Over the past year, RNAZ quarterly long term assets has changed by -$390.80 K (-54.71%)